You are interested in buying shares of Citius Pharmaceuticals (CTXR). Tutorial

citius pharmaceuticals

Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets critical care products. It primarily focuses on developing anti-infective, cancer care, prescription and mesenchymal stem cell therapy products. The company is developing Mino-Lok, an antibiotic lockout solution used to treat patients with catheter-related bloodstream infections by retrieving the infected catheter, which is in phase III clinical trials; Mino-Wrap, a liquefying gel-based wrap for the reduction of tissue expander infections after Halo-Lido breast reconstructive surgeries, a topical corticosteroid-lidocaine formulation that is intended to provide anti-inflammatory and anesthetic relief to people suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory illness syndrome.

You are interested in buying shares of Citius Pharmaceuticals (CTXR). Tutorial

Do you want to buy Citius Pharmaceuticals (CTXR) shares on Nasdaq easily and using a regulated and reliable broker? Are you interested in the fact of making your earnings profitable per month and making profits on the stock market? Today I am going to show you how you can register an account with DeGiro , a reliable German investment broker with low commissions, and how you can get your first share of Citius Pharmaceuticals, Inc. (CTXR) (CTXR) quickly and easily. simple.

The tutorial is intuitive :

  • To start we are going to register in Degiro, an investment platform in which we will buy shares of the company Citius Pharmaceuticals, Inc. (CTXR), (CTXR).
  • Next we will add funds to execute the 1st investment.
  • When we finally have the funds, we must look for the company Citius Pharmaceuticals by the TICKER, which is CTXR.
  • To finish, we will only go on to indicate the number of shares that we will buy, value and the type of order.

The tutorial may have been a little bit detailed for you, so I will summarize the process with images:

How to open an account in DEGIRO.

To start we are going to register in DEGIRO from the following link :

buy shares of Citius Pharmaceuticals, Inc. (CTXR)

It will ask us for an email, a name and a password to access, and then we must follow from the link that they have sent us by email address.

Soon Degiro will ask us for some important data with which they will verify our identity card . We must have our passport, national identity document or driving license, the mobile number and the bank account number that we are going to use to make our 1st deposit. If you don’t know how this format works, you can check this simple tutorial article that we wrote at Educacep .

stock Citius Pharmaceuticals

Once our account is authorized, we can deposit money from the Deposit/Withdraw section. We can make a transaction that will take between 1-3 days, or make the deposit instantly using Sofort, a 100% secure and very reliable payment gateway.

deposit money Citius Pharmaceuticals

How to buy Citius Pharmaceuticals (CTXR) shares via degiro

Once we have the money we have the possibility of buying our 1st share. You can go to the place order button that is located in the upper right corner or use the turn search engine and type the ticker. In the next screenshot you will see that I have written the Amazon Ticker but you have to enter (CTXR), the Citius Pharmaceuticals ticker. As we are talking about an action, we will discover that the related businesses and companies are listed and there we will see to find Citius Pharmaceuticals. The most essential thing is that the ticker, the name of the company and the market in which it is listed coincide. Amazon is listed on Nasdaq (NDQ) and in your case Citius Pharmaceuticals, Inc. (CTXR) is listed on Nasdaq. This step is very fundamental so make no mistake.

American stock market opens what hours Citius Pharmaceuticals

At the time of developing the order we will have to be attentive to what I am going to explain to you . We have the possibility of proceeding to place a limit or market order. Think you want to buy a share of Citius Pharmaceuticals at 2.3500, but its price is currently quite prominent. With a limit order we will adapt the value at which we calculate to make the purchase and until there are no shares for sale at this price, the acquisition of the share will not be made. With a market order DEGIRO will buy the number of shares that we have added to the currently selling price, which would be very close to the current trading price.

Citius Pharmaceuticals, Inc. (CTXR) Stock Limited Order

In any case, it is convenient that you look at the order: permanent or of the day . To serve as an example, in Spain, the stock market is in the morning until 1:00 p.m., and in the US it corresponds to the afternoon schedule in Spain. If the order is fixed, it will be kept until the point in which it gets executed, but if you select the “of the day” option, at the end of that day, if it has not been carried out, it will be removed from your Activity history – Orders slopes.

Hopefully this short text has helped you to invest in Citius Pharmaceuticals.

  Company information
  • Citius Pharmaceuticals, Inc. (CTXR) Address: 11 Commerce Drive First Floor Cranford, NJ 07016 United States 908 967 6677 Website:
  • Ticker: CTXR
  • Sector: The sector is unknown
  • Industry: Industry
  • Number of employees: 10
  • Listed market: Nasdaq
  • Value last year: $2,3500

company executives

Name Title Payment exercised Year of birth
Mr. Leonard L. Mazur Executive President and Sec. 410k N/A 1945
Mr. Myron Z. Holubiak President, CEO and Director 735k N/A 1947
Mr. Jaime Bartushak Financial Director and Accounting Director 440k N/A 1968
Dr. Myron S. Czuczman MD Executive Vice President and Medical Director 436.42k N/A 1959
Mr. Gary F. Talarico Executive Vice President of Operations N/A N/A 1955

Recent Citius Pharmaceuticals Events:

Recent Events July 14, 2020 Filed Full 8-K: Change of Directors or Senior Officers, Financial Statements and July 10, 2020 Filed Full 8-K: Notice of Exclusion or Breach of a Continuing Listing Rule June 26, 2020 Filed Complete 8-K: Other Events, Financial Statements, and Exhibits June 02, 2020 Completely Filed 8-K: Other Events, Financial Statements, and Exhibits May 26, 2020 Completely Filed 8-K: Other Events, Financial Statements, and Exhibits